Navigation Links
Montclair Breast Center Introduces Online Breast Cancer Risk Quiz

Montclair, NJ (PRWEB) July 25, 2013

In June of 2013, actress Angelina Jolie announced that a genetic screening test revealed she carried a BRCA 1 genetic mutation that elevated her chances of developing breast or ovarian cancer. Her decision to undergo a double mastectomy created a storm of awareness and controversy about genetic testing and surgical procedures for breast cancer prevention.

Angelina Jolie’s condition is known as hereditary breast and ovarian cancer syndrome and accounts for 5–10% of all breast cancer cases. But according to Montclair Breast Center Founder and Director, Dr. Nancy Elliott, there is much more to being aware and vigilant about breast health than this one issue of genetic testing. She says, “Genetic testing is critical for some women, but genetic mutations account for cancers in a very small population of women overall, so it is critical to become savvy about all risk factors for breast cancer. Women need to know their family medical history of cancers and other disease, understand how diet, weight and exercise can impact their risk factors and certainly learn more about genetic testing if it is indicated to be of value for them.”

To increase awareness of breast health and risk factors for breast cancer, Dr. Elliott has introduced a free Montclair Breast Center Risk Quiz, available online at Surprisingly, the risk quiz consists of just eight short questions and an easy point system for estimating risk for breast cancer from 0–10 (average risk), 11–19 (moderate risk), 20 & Over (high risk) to Over 30 (highest risk). While not represented as a scientific result, Dr. Elliott suggests that this easy and quick quiz is a practical first step in helping women become aware of risk factors for breast cancer and may help guide them in their quest for more information and awareness of breast health.

According to Dr. Elliott, the most important factor in early detection of breast cancer for women at even average risk for breast cancer is to have a yearly mammogram with consistent comparisons of consecutive mammograms. She points out that of all patients who began and continued their screening at Montclair Breast Center and were diagnosed with breast cancer in 2012, 95% were diagnosed at the most treatable Stages 0 or 1, while the national average for such early diagnosis in all women is just 60%.

Dr. Melissa Lee, Director of Breast Services and Clinical Breast Radiologist, points out that the diagnostic technology available at Montclair Breast Center has never been better, with the recent introduction of 3D mammography (breast tomosynthesis).

Dr. Lee says, “The Selenia Dimensions 3D mammography system used at Montclair Breast Center offers exceptionally sharp breast images that provide the ability to identify and characterize individual breast structures without the confusion of overlaying tissue.” During a 3D mammogram, multiple, low-dose images of the breast are acquired at different angles and then used to produce a 3D reconstruction of the breast.

Statistics indicate that one in eight women will develop breast cancer sometime in her life. The stage at which breast cancer is detected influences a woman’s chance of survival and if detected early, the five-year survival rate is 97 percent.

To view, download or print the Montclair Breast Center Risk Quiz, visit If you would like to schedule a 3D mammogram or have questions about 3D mammography or determining your risk for breast cancer, call 973-509-1818.

About Montclair Breast Center: Montclair Breast Center is a premier multidisciplinary breast center located at 37 N. Fullerton Avenue in Montclair, NJ, specializing in proactive breast healthcare, risk-reduction techniques and the early detection and treatment of breast cancer. Our nationally recognized, dedicated team of breast imagers and breast surgeons use the most sophisticated technologies and are committed to providing better breast care than anywhere. In 1998, Montclair Breast Center became an out-of-network breast center to provide care solely dictated by the needs of our patients, uncompromised by the restrictions and limitations imposed by managed healthcare corporations.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Montclair Breast Center introduces 3D Mammography.
2. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
3. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
4. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
5. Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA
6. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
7. Agendia Reports More Than 20,000 MammaPrint Breast Cancer Recurrence Results
8. Stereotactic Breast Biopsy introduced with Fischer-Giotto Image at American Society of Breast Surgeons course
9. Robert Lowen MD, Expert Bay Area Plastic Surgeon, Announces Cutting-Edge 3-D Crisalix Imaging Technology to Aid Patients in Choosing their Breast Implant Size
10. Patti Flint MD, A Top Female Plastic Surgeon in the Southwest, Is Proud To Offer Cutting-Edge 3D Crisalix Technology to Patients When Selecting Breast Implants
11. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
Post Your Comments:
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... environment are paramount. Insertion points for in-line sensors can represent a weak spot ... InTrac 781/784 series of retractable sensor housings , which are designed to ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Inc., on being named to Deloitte's 2015 Technology Fast 500 list of the ... manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic tooth ...
(Date:11/24/2015)... 24, 2015 Capricor Therapeutics, Inc. ... the discovery, development and commercialization of first-in-class therapeutics, today ... Officer, is scheduled to present at the 2015 Piper ... a.m. EST, at The Lotte New York Palace Hotel ... . --> . ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
Breaking Biology News(10 mins):